SLC7A11 and neoplasm: Platelets are versatile cells that are part of the pathological processes of tumor cell hematogenous metastasis [81], and platelet-derived EVs from NPC patients upregulate integrin β3 (ITGB3) while elevating the expression of solute carrier family 7 member 11 (SLC7A11) by activating the MAPK/ERK/ATF4/Nrf2 axis and increasing protein stability.